Pulmonx (LUNG) Total Current Liabilities (2019 - 2025)

Pulmonx (LUNG) has 7 years of Total Current Liabilities data on file, last reported at $20.1 million in Q4 2025.

• Total Current Liabilities for Q4 2025 came in at $20.1 million, down 17.92% year-over-year; the trailing twelve-month figure through Dec 2025 was $20.1 million (down 17.92% YoY), and the FY2025 annual result was $20.1 million, down 17.92% from the prior year.
• Total Current Liabilities fell to $20.1 million in Q4 2025 per LUNG's latest filing, from $22.9 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $24.9 million in Q1 2025 and troughed at $14.0 million in Q1 2021.
• A 5-year average of $20.0 million and a median of $20.3 million in 2022 frame the typical range for Total Current Liabilities.
• The sharpest annual moves came in 2021 and 2025: Total Current Liabilities soared 46.41% in 2021, then fell 17.92% in 2025.
• A 5-year view of Total Current Liabilities shows it stood at $17.6 million in 2021, then grew by 5.37% to $18.5 million in 2022, then grew by 25.23% to $23.2 million in 2023, then gained by 5.53% to $24.4 million in 2024, then slipped by 17.92% to $20.1 million in 2025.
• Business Quant data shows LUNG's Total Current Liabilities at $20.1 million in Q4 2025, $22.9 million in Q3 2025, and $22.4 million in Q2 2025.